Consent Order Resolves Charges That Biovail and Elan Agreement Unreasonably Restrained Competition In Market for Generic Anti-hypertension Drug
Date
The Federal Trade Commission today voted to accept for public comment a proposed consent order with two generic drug manufacturers to resolve charges that they entered into an agreement that...